Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bizzini

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1984
[Immune behavior in women with operable breast cancer]J C Bazin, B Bizzini, S Gorgone, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1984
[Action of the immunoadjuvant P 40 in women with operable breast cancer]J C Bazin, B Bizzini, S Gorgone, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2000
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaquesC D Pauza, P Trivedi, M Wallace, et al.
Immunopharmacology|August 1, 1985
The restoration of impaired macrophage functions using as immunomodulator the Corynebacterium granulosum-derived P40 fractionP Mastroeni, B Bizzini, L Bonina, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDSJ F Zagury, A Lachgar, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 1999
Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic proteinH Le Buanec, A Lachgar, R D'Anna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 25, 1999
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapyD Zagury, H Lecoq, I Gervi, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Tat toxoid as a component of a preventive vaccine in seronegative subjectsA Gringeri, E Santagostino, M Muça-Perja, et al.
International Surgery|January 1, 1982
Immunological investigation and immunotherapy in patients operated on for breast carcinomaJ Reynier, R Villet, J C Bazin, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1980
[Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40 (author's transl)]J Reynier, J C Bazin, B Bizzini, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1984
[Immune behavior in women with operable breast cancer]J C Bazin, B Bizzini, S Gorgone, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1984
[Action of the immunoadjuvant P 40 in women with operable breast cancer]J C Bazin, B Bizzini, S Gorgone, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2000
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaquesC D Pauza, P Trivedi, M Wallace, et al.
Immunopharmacology|August 1, 1985
The restoration of impaired macrophage functions using as immunomodulator the Corynebacterium granulosum-derived P40 fractionP Mastroeni, B Bizzini, L Bonina, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDSJ F Zagury, A Lachgar, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 1999
Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic proteinH Le Buanec, A Lachgar, R D'Anna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 25, 1999
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapyD Zagury, H Lecoq, I Gervi, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Tat toxoid as a component of a preventive vaccine in seronegative subjectsA Gringeri, E Santagostino, M Muça-Perja, et al.
International Surgery|January 1, 1982
Immunological investigation and immunotherapy in patients operated on for breast carcinomaJ Reynier, R Villet, J C Bazin, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1980
[Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40 (author's transl)]J Reynier, J C Bazin, B Bizzini, et al.
Pageof 16